Literature DB >> 9431373

Bronchiolitis obliterans organizing pneumonia associated with acute Mycoplasma pneumoniae infection.

J M Llibre1, A Urban, E Garcia, M A Carrasco, C Murcia.   

Abstract

A patient with bronchiolitis obliterans organizing pneumonia (BOOP) associated with acute Mycoplasma pneumoniae infection is described. Although mycoplasmas have occasionally been associated with bronchiolitis obliterans, to the best of our knowledge, this is the first well-documented case of BOOP associated with M. pneumoniae infection. The diagnosis of BOOP was made by open-lung biopsy after fiberoptic transbronchial biopsy proved nondiagnostic. Corticosteroid therapy was administered and a dramatic improvement was observed; the patient remained without complaints during a 3-year follow-up period.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9431373     DOI: 10.1086/516124

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection.

Authors:  M Narita; H Tanaka; S Yamada; S Abe; T Ariga; Y Sakiyama
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  Fatal outcomes in family transmission of Mycoplasma pneumoniae.

Authors:  T R Kannan; R D Hardy; J J Coalson; D C Cavuoti; J D Siegel; M Cagle; O Musatovova; C Herrera; J B Baseman
Journal:  Clin Infect Dis       Date:  2011-11-03       Impact factor: 9.079

3.  Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model.

Authors:  T R Kannan; Jacqueline J Coalson; Marianna Cagle; Oxana Musatovova; R Doug Hardy; Joel B Baseman
Journal:  J Infect Dis       Date:  2011-09-28       Impact factor: 5.226

4.  Pulmonary migratory infiltrates due to mycoplasma infection: case report and review of the literature.

Authors:  Wenjie You; Bi Chen; Jing Li; Juan Shou; Shan Xue; Xueqing Liu; Handong Jiang
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

5.  Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection.

Authors:  Judy M Hickman-Davis; Carmel McNicholas-Bevensee; Ian C Davis; He-Ping Ma; Glenda C Davis; Charles A Bosworth; Sadis Matalon
Journal:  Am J Respir Crit Care Med       Date:  2005-10-27       Impact factor: 21.405

6.  Humoral and cellular immunity in children with Mycoplasma pneumoniae infection: a 1-year prospective study.

Authors:  Iwona Stelmach; Malgorzata Podsiadłowicz-Borzecka; Tomasz Grzelewski; Pawel Majak; Wlodzimierz Stelmach; Joanna Jerzyńska; Marta Popławska; Jaroslaw Dziadek
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

7.  Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon.

Authors:  M Narita; H Tanaka; S Abe; S Yamada; M Kubota; T Togashi
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

Review 8.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review.

Authors:  Sara Al-Ghanem; Hamdan Al-Jahdali; Hanaa Bamefleh; Ali Nawaz Khan
Journal:  Ann Thorac Med       Date:  2008-04       Impact factor: 2.219

10.  Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells.

Authors:  Kathryn Chmura; Xiyuan Bai; Mari Nakamura; Pitchaimani Kandasamy; Mischa McGibney; Koji Kuronuma; Hiroki Mitsuzawa; Dennis R Voelker; Edward D Chan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-16       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.